Brief: Jasper Therapeutics - On Jan 18, Received A Letter From Nasdaq Notifying Co That It Has Regained Full Compliance With Minimum Bid Price Requirement
19/01/2023 13:20
Jan 19 (Reuters) - Jasper Therapeutics Inc JSPR.O :
* JASPER THERAPEUTICS - ON JAN 18, RECEIVED A LETTER FROM
NASDAQ
NOTIFYING CO THAT IT HAS REGAINED FULL COMPLIANCE WITH MINIMUM
BID PRICE REQUIREMENT
Further company coverage: JSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma